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We have sequenced a cDNA for sex hormone-binding globulin (SHBG) isolated from a phage 2gtl 1 human 
liver cDNA library. The library was screened with a radiolabeled rat androgen-binding protein (ABP) 
cDNA, and the abundance of SHBG cDNAs was 1 in 750 000 plaques examined. The largest human SHBG 
cDNA (1194 base-pairs) contained a reading frame for 381 amino acids. This comprised 8amino acids of 
a signal peptide followed by 373 residues tarting with the known NH2-terminal sequence of human SHBG, 
and ending with a termination codon. The predicted polypeptide Mr of SHBG is 40 509, and sites of attach- 
ment of one O-linked (residue 7) and two N-linked oligosaccharide (residues 351 and 367) chains were iden- 
tified. Purified SHBG was photoaffinity-labeled with zt6-[3H]testosterone a d cleaved with trypsin. The la- 
beled tryptic fragment was isolated by reverse-phase HPLC, and its NH2-terminal sequence was determined. 
The results suggest that a portion of the steroid-binding domain of SHBG is located between residue 296 
and the 35 predominantly h drophilic residues at the C-terminus of the protein. 
cDNA cloning; Amino acid sequence; Sex hormone-binding globulin; Steroid-binding domain 
1. INTRODUCTION 
SHBG is a glycoprotein in human serum that 
binds testosterone and estradiol with high affinity 
and is thought o regulate their entry into cells [1]. 
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(TeBG) and sex-steroid-binding protein (SBP); ABP, 
androgen-binding protein; za6-testosterone, 17fl-hydrox- 
yandrosta-4,6-dien-3-one; SSPE, 150 mM NaCI/10 mM 
NaH2PO4H20/1 mM EDTA (pH 7.4); SSC, 150 mM 
NaC1/15 mM sodium acetate (pH 7.4); Denhardt's solu- 
tion, 0.02% Ficoll/0.02% polyvinylpyrrolidone/0.02% 
bovine serum albumin (Pentax, fraction V) in H20 (w/v) 
Human SHBG has been purified to apparent 
homogeneity, but analyses of its amino acid com- 
position and carbohydrate content have produced 
conflicting data [2-7]. In its native form, SHBG is 
composed of two identical subunits which appear 
to associate to form a single steroid-binding site 
[2,6-8]. The molecular composition of the SHBG 
steroid-binding domain has not, however, been 
determined; despite the fact that it can be 
photoaffinity-labeled with A6-[3H]testosterone [9]. 
It is known that SHBG is produced by 
hepatocytes [10], and its synthesis is thought o be 
stimulated by thyroid hormone [10] and estrogens 
[11], and decreased by androgens [11]. The Sertoli 
ceils of the testis also produce a protein that is 
physicochemically and immunochemically closely 
related to plasma SHBG [12], and is generally 
referred to as testicular androgen-binding protein 
(ABP). The production of ABP by Sertoli cells is 
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induced by testosterone and follicle-stimulating 
hormone [13], and its synthesis therefore appears 
to be regulated ifferently from that of SHBG. 
This may be attributed to the presence of different 
genes for these two proteins, but may also be the 
result of cell-specific differences in the expression 
of a single gene. In order to begin to address these 
questions we have isolated a cDNA for human 
SHBG by taking advantage of its ability to 
hybridize with a rat ABP cDNA isolated from a 
testicular expression library [14]. This has enabled 
us to predict its amino acid sequence and to locate 
a region of the molecule that appears to be in- 
volved in steroid binding. 
2. MATERIALS AND METHODS 
2.1. cDNA cloning 
A cDNA for rat ABP [14] was used as a probe 
to screen a Agtll human liver cDNA library that 
was kindly provided by S.L.C. Woo (Baylor Col- 
lege of Medicine, Houston, TX). The rat ABP 
cDNA comprised two EcoRI fragments that had 
been subcloned into the EcoRI site of pBR322 
[14,15]. The library was screened using E. coli 
(strain Y1088) as the host bacteria t a density of 
3 × 10 4 plaques/150 mm culture plate. Nitrocellu- 
lose filters were used to transfer DNA, and were 
prehybridized at 37°C in a buffer (5 × SSPE, 5 × 
Denhardt's olution, 0.1°70 SDS) containing 40O7o 
deionized formamide and 100/zg denatured 
salmon sperm DNA/ml. Both rat ABP cDNA 
EcoRI fragments were nick-translated in the 
presence of 32p-labeled CTP [15], and the resul- 
tant probes were mixed and hybridized with the 
filters for 16 h at 37°C in prehybridization buffer 
(2 x 106 cpm/ml). The filters were washed 3 times 
at room temperature in 2 × SSC/0.1 °7o SDS, once 
for 30 min in 1 × SSC/0,1% SDS at 37°C, and 
twice for 30 min in 0.2 × SSC/0.1% SDS at 37°C. 
Autoradiography was performed overnight at 
-80°C using XAR film (Eastman Kodak, 
Rochester, NY) and Dupont Cronex R HI-Plus XH 
intensifying screens (DuPont Canada, Markham, 
Ontario). 
2.2. DNA sequencing 
When the largest SHBG cDNA was excised from 
the Agt 11 cloning vector two EcoRI fragments were 
obtained and were subcloned into the EcoRI site of 
pBR322 for amplification. After excision from the 
plasmid with EcoRI, both fragments were isolated 
by electroelution from a preparative polyacryl- 
amide gel [15], and digested with appropriate re- 
striction enzymes (fig. 1). The resultant fragments 
were subcloned into M13mpl8 and Ml3mpl9 
bacteriophage vectors to produce single-stranded 
templates for sequencing by the dideoxy-chain ter- 
mination method [16]. 
2.3. Photolabeling of SHBG and preparation of 
tryptic fragments 
Human SHBG was purified [9,17] and 
photolabeled with A6-[3H]testosterone [9], and the 
product was analysed by SDS-PAGE and 
fluorography [9]. About 200/zg photolabeled 
SHBG was equilibrated with trypsin buffer 
(50 mM Tris, 30 mM KCI, 2 mM MgCI2, pH 7.5, 
at 22°C), 20/zg N-tosyl-L-phenylalanine chloro- 
methyl-treated trypsin was added, and igestion 
was performed at 37°C for 24 h. Preliminary ex- 
periments indicated that digestion was completed 
using an enzyme:substrate ratio of 1:10 within 
16 h under these conditions. The tryptic digest was 
fractionated by HPLC as follows: the sample was 
lyophilized, resuspended in 0.1 070 trifluoroacetic 
acid, and injected onto a Vydac C-18 reverse-phase 
HPLC column (4.6 × 250 mm (i.d.), particle size 
5/~m). The initial solvent (A) consisted of 507o 
acetonitrile and 95% water containing 0.1°70 
trifluoroacetic acid (v/v), and the second solvent 
(B) was 95°7o acetonitrile and 507o water containing 
0.1 07o trifluoroacetic acid (v/v). Elution was per- 
formed using a linear gradient from 0 to 80% sol- 
vent B at a flow rate of 1 ml/min over 90 min, and 
the effluent was monitored by UV absorbance at 
206 nm. An aliquot (5/A) of each fraction 
(0.25 ml) collected from the HPLC column was 
counted, and the radiolabeled tryptic fragment was 
detected in a fraction that eluted in the presence of 
4107o acetonitrile. 
2.4. NH2-terminal sequence analysis 
The fraction containing the photolabeled tryptic 
fragment was reconstituted in 0.1 °7o SDS, and the 
volume was reduced to 100/zl under nitrogen. The 
sample was subjected to Edman degradation i the 
presence of Polybrene [18] in a gas-phase se- 
quenator (Applied Biosystems, Foster City, CA) 
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equipped with automatic converting flask and 
microprocessor. Phenylthiohydantoin-amino acids 
were determined by reverse-phase HPLC. 
3. RESULTS AND DISCUSSION 
As a result of screening 1.5 × 10 6 individual 
plaques from a male human liver cDNA library 
with a rat ABP cDNA probe, we were only able to 
isolate two SHBG cDNAs. Their abundance 
therefore appears to be very low when compared to 
the number of cDNAs for corticosteroid-binding 
globulin (CBG) we have isolated from the same 
library [14]. This difference may reflect differences 
in the relative amounts of mRNAs for these pro- 
teins in the liver, and contribute to the 10-50-fold 
higher plasma concentrations of CBG [19] when 
compared to SHBG [20,21]. 
The largest of the two SHBG cDNAs isolated 
contained two EcoRI fragments (0.55 and 0.64 kb 
in length), while the other only contained a single 
0.55 kb insert. The 0.55 kb fragments from both 
clones hybridize with each other, and represent the 
3'-end of the SHBG mRNA (fig. 1). Both the 0.64 
and 0.55 kb EcoRI fragments of the SHBG cDNA 
we have sequenced (fig.l) hybridize with the cor- 
responding EcoRI fragments of rat ABP cDNA 
[14]. In fact, when the rat ABP [22] and human 
SHBG cDNA sequences are compared there is only 
a 23°70 mismatch in nucleotide sequences over a 
1153 nucleotide overlap, and 68% identity with 
respect o the amino acid sequences of the mature 
proteins (not shown). 
The human SHBG cDNA we have sequenced is
not full length, but it does contain the entire 
coding region for the mature SHBG peptide, as 
well as a portion o f  the leader sequence (fig.2). 
This was ascertained by comparing the predicted 
amino acid sequence from the cDNA with the 
known NH2-terminal sequence of human SHBG 
[6] underlined in fig.2. The cDNA-deduced amino 
acid sequence also agrees with the sequence recent- 
ly obtained by direct chemical methods [23], and 
confirms the presence of a Leu at the 
NH2-terminus of the protein [4,6]. Residue no.7 
from the amino-terminus appears to be the site of 
attachment of an oligosaccharide [6,23], and the 
cDNA confirms the presence of a threonine in this 
position [23]. It is therefore likely that this is the 
site of attachment of the single O-linked oligosac- 
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Fig.1. Partial restriction map of human liver SHBG 
cDNA and a diagrammatic summary of the sequencing 
strategy. Restriction fragments were subcloned into 
M 13mp 18 and M 13mp 19, and single-stranded templates 
were sequenced by the dideoxy chain termination 
method [16] in the directions hown by the arrows. 
charide chain predicted for each SHBG subunit 
[24]. The amino acid sequence of SHBG we have 
deduced from its cDNA also contains two Asn-X- 
Ser/Thr (where X is not a Pro) consensus e- 
quences [25] for the attachment of N-linked 
oligosaccharide chains (fig.2), and these both ap- 
pear to be utilized [23,24]. 
Although the 3' -end of the human SHBG cDNA 
ends with a poly(A)-rich region, it does not appear 
to represent he poly(A) tail of the mRNA; (i) 
because it is followed by a single G that is not part 
of the EcoRI linker, and (ii) because it is not 
preceded by the usual eucaryotic polyadenylation 
signals (AATAAA or AAGAAA). We therefore 
assume that this poly(A)-rich region was used as 
the site for oligo(dT)-primed reverse transcription 
of the SHBG mRNA, which most probably con- 
tains a longer 3'-untranslated region than is 
represented by the cDNA. 
The use of A6-[3H]testosterone enabled us to 
photolabel an amino acid within the steroid- 
binding site of SHBG, and to isolate a tryptic frag- 
ment generated by cleavage at residue 295 (Lys). 
The NHE-terminal sequence of the photolabeled 
fragment includes the only other lysine before the 
C-terminus of the molecule, but there are two 
arginine residues that may be targets for trypsin at 
positions 343 and 352. Preliminary analyses of the 
secondary structure of SHBG, however, indicate 
that both arginines are located within a 
predominantly hydrophilic region of the molecule; 
extending from residue 338 to the C-terminus of 
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-8 Gln His Thr A_~ Gln GIy Trp Ala Leu Ara Pro Val Leu Pro ~r  Gln Set Ala His 
i CAG CAC ACC CGC CAG GGA TGG GCC CTG AGA CCT GTT CTC CCC ACC CAG AGT GCC CAC 
Pro Pro Ala Val His Leu SeE ASn Glv Pro Glv Glq Glu Pro Ile Ala Val Mat Thr 
61 CCT CCG GCT GTC CAC CTC AGC AAT GGC CCA GGA CAA GAG CCT ATC GCT GTC ATG ACC 
Asp Leu Thr Lys IZe Thr Lys Thr Set Sat Bar Pho Glu Val Arg Thr Trp Asp Pro 
121 GAC CTC ACC AAG ATC ACA AAA ACC TCC TCC TCC TTT GAG GTT CGA ACC TGG GAC CCA 
GZy Val Ile Phe Tyr GIy Asp Thr Asn Pro Lya Asp Asp Trp Phe Met Leu GIy Leu 
181 GGA GTG ATT TTT TAT GGG GAT ACC AAC CCT AAG GAT GAC TGG ~-x-i ATG CTG GGA CTT 
Asp GZy Arg Pro GZu Ile Gln Leu His Asn His  Trp AZa Gin Leu Thr Val GIy Ala 
241 GAC GGC AGG CCT GAG ATC CAA CTG CAC AAT CAC TGG GCC CAG CTT ACG GTG GGT GCT 
Pro Arg Leu Asp Asp Giy Arg Trp His Gln Val Glu Val Lya Met Glu GIy Asp Set 
301 CCA CGG CTG GAT GAT GGG AGA TGG CAC CAG GTG GAA GTC AAG ATG GAG GGG GAC TCT 
Leu Leu GZu Val Asp GZy Glu GIu Val Leu Arg Leu Arg Gln Val Set GIy Pro Leu 
361 CTG CTG GAG GTG GAT GGG GAG GAG GTG CTG CGC CTG AGA CAG GTC TCT GGG CCC CTG 
Ser Lya Arg His Pro Ile Mat Arg Ila Ala Leu GIy GIy Leu Leu Phe Pro Ala Ser 
421 AGC AAA CGC CAT CCC ATC ATG AGG ATT GOQ CTT GGG GGG CTG CTC TTC CCC GCT TCC 
Leu Arg Leu Pro Leu Val Pro Ala Leu Asp GZy Cya Leu Arg Arg Asp Set Trp Leu 
481 CTT CGG TTG CCG CTG GTT CCT GCC CTG GAT GGC TGC CTG CGC CGG GAT TCC TGG CTG 
Lys Gln Ala Glu Ile Ser Ala Ser Ala Pro Thr Set Leu Arg Ser Cys Asp Val Glu 
541 AAA CAG GCC GAG ATC TCA GCA TCT GCC CCC ACT AGC CTC AGA AGC TGT GAT GTA GAA 
ASn Pro GIy Ile Phe Leu Pro Pro GIy Thr GZn Ala Glu Phe Asn Leu Ar~ Asp Ile 
601 AAT CCC GGG ATA TTT CTC CCT CCA GGG ACT CAG GCA GAA TTC AAT CTC CGA GAC ATT 
Gln Pro His Ala GZu Pro Trp Ala Phe Sar Leu Asp Leu GZy Leu Lys Gln AZa Ala 
661 CAG CCT CAT GCA GAG CCC TGG GCC TTC TCT TTG GAC CTG GGA CTC AAG CAG GCA GCA 
Set GIy His Leu Leu AZa Leu GIy Thr Pro Glu Amn Pro Set Trp Leu Ser Leu His 
721 TCA GGC CAC CTC CTT GCT CTT GGG ACA CCA GAG AAC CCA TCT TGG CTC AGT CTC CAC 
Gln Asp GZn Lys Val Val Phe Ser Ser GZy Set GIy Pro GIy Leu Asp Leu Pro Leu 
781 CAA GAT CAA AAG GTG GTG TTC TCT TCT GGG TCG GGG CCA GGG CTG GAT CTG CCC CTG 
Leu GIy Leu Pro Leu Gin Leu Lya Leu Set Met Set Arg Val Val Leu Set Gln GIy 
841 TTG GGA CTC CCT CTT CAG CTG AAG CTG AGT ATG TCC AGG GTG GTC TTG AGC CAA GGG 
Lys Met Lys Ala Leu Ala Leu Pro Pro__Leu_ GIy Le.u .Ala .Pro Le.u ._Leu Asn .Leu. Tr~ 
9Ol ~G ATG JULG ~c'c"c~'~.,66"c~,'~r"c~:~ '~A ~,~,c',3'R~" Gbi' ccc  CTc c'r'r J~,c c rc  TUG 
.Lys..pro.U1.. g1¥ Arg  Leu l~e  Leu .GZy.A.I.% ..Lo.u.pro. G1¥ ~lu  ASp sar  Set  Thr  Sat  
961 AAG ccr CAA GGG CGT ~'T~'~I~"  ~ Gcr TTA CCA GGA GAA GAC TCT TCC Ace TCT 
Cya Leu Asn Gly Leu Trp Ala Gin G1¥ Gln Arg Leu Asp Val Asp Gln Ala Leu Aen 
1021 TGC CTG AAT GGC CTT TGG GCA CAA GGT CAG AGG CTG GAT GTG GAC CAG GCC CTG AAC 
Set His Glu Ile Trp Thr His $er Cys Pro Gln Ser Pro G1¥ Amen Gly Thr Asp Ala 
1081 AGC CAT GAG ATC TGG ACT CAC AGC TGC CCC CAG AGC CCA GGC AAT GGC ACT GAC GCT 
His --- 
1141 CAT TAA AGCTCCACCTAAGAACCCCH;-~-LGAAAGTT G 
May 1987 
As~ 12 
GAC 
Phe 32 
Glu  52 
GAG 
Arg 72 
CGA 
GIy 92 
GGA 
Va l  112 
GTG 
Thr  132 
ACC 
Asn 152 
AAC 
Asp 172 
GAC 
Ser  192 
TCA 
Pro 212 
CCC 
Gly 232 
GGC 
Leu 252 
CTC 
Val 272 
GTC 
Set  292 
TCG 
.A.la 31a 
GCC 
Phe 332 
Arg 352 
AGA 
Set 372 
TCC 
Fig.2. The amino acid sequence of human SHBG deduced from the sequence of its cDNA. The numbering of amino 
acids is based on the known NH2-terminal sequence [6], and this is underlined (solid). The potential positions of one 
O-linked carbohydrate (©) and two N-linked carbohydrate chains (e) are identified. The dashed underline indicates the 
NHE-terminal mino acid sequence of the tryptic fragment that was photolabeled with A6-[3H]testosterone. Gaps in this 
sequence represent amino acids for which an ambiguous signal was obtained. 
103 
Volume 215, number 1 FEBS LETTERS May 1987 
the protein and including two possible N-linked 
carbohydrate chains at residues 351 and 367. 
Although this is obviously an exposed surface 
region of the molecule, the presence of two car- 
bohydrate chains may protect the arginines from 
trypsin, and the labeled fragment could include the 
C-terminus of the protein. Nevertheless, because 
the steroid-binding site is likely to be located 
within a hydrophobic pocket, the photolabeled 
amino acid is probably not located in this 
hydrophilic C-terminal region. Further studies are 
required to identify the amino acid that is 
photolabeled with za6-[3H]testosterone, and to 
define the boundaries of the steroid binding site, 
but it is anticipated that the availability of a cDNA 
will enable us to address these and other questions 
related to the structure and function of this 
protein. 
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